Q32 Bio (QTTB) EBITDA (2017 - 2026)
Q32 Bio (QTTB) posted quarterly EBITDA of -$7.7 million for Q1 2026, up 36.85% year-over-year from -$5.6 million in Q1 2025, and down 116.83% quarter-over-quarter from $45.9 million in Q4 2025.
Q32 Bio (QTTB) EBITDA (2017 - 2026) Analysis & Trends
Q32 Bio's EBITDA history runs 10 years deep, the most recent figure standing at -$7.7 million for Q1 2026.
- In Q1 2026, EBITDA rose 36.85% year-over-year to -$7.7 million; the TTM figure through Mar 2026 stood at $21.4 million (up 133.72% YoY), while the FY2025 annual figure was $16.9 million, up 125.57% from the prior year.
- EBITDA for Q1 2026 stood at -$7.7 million, down from $45.9 million in the prior quarter.
- The five-year high for EBITDA was $45.9 million in Q4 2025, with the low at -$37.6 million in Q1 2022.
- The 5-year median for EBITDA is -$14.5 million (2024), against an average of -$14.0 million.
- The sharpest annual moves came in 2022 and 2025: EBITDA slumped 3285.96% in 2022, then soared 415.84% in 2025.
- Q32 Bio's EBITDA stood at -$34.5 million in 2022, then climbed by 25.18% to -$25.8 million in 2023, then jumped by 43.72% to -$14.5 million in 2024, then jumped by 415.84% to $45.9 million in 2025, then plunged by 116.83% to -$7.7 million in 2026.
- Business Quant data shows QTTB's EBITDA at -$7.7 million in Q1 2026, $45.9 million in Q4 2025, and -$7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | -9.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.12 Mn |
| Mar 31, 2026 | -7.72 Mn |
| Dec 31, 2025 | 45.88 Mn |
| Sep 30, 2025 | -7.58 Mn |
| Jun 30, 2025 | -9.17 Mn |
| Mar 31, 2025 | -12.23 Mn |
| Dec 31, 2024 | -14.53 Mn |
| Sep 30, 2024 | -18.81 Mn |
| Jun 30, 2024 | -17.92 Mn |
| Mar 31, 2024 | -14.84 Mn |
| Dec 31, 2023 | -25.81 Mn |
| Sep 30, 2023 | -7.80 Mn |
| Jun 30, 2023 | -7.28 Mn |
| Mar 31, 2023 | -7.37 Mn |
| Dec 31, 2022 | -34.49 Mn |
| Sep 30, 2022 | -32.86 Mn |
| Jun 30, 2022 | -28.31 Mn |
| Mar 31, 2022 | -37.62 Mn |
| Dec 31, 2021 | -33.63 Mn |
| Sep 30, 2021 | -30.66 Mn |